DPT expands plant in San Antonio

San Antonio-based CDMO DPT Laboratories and its sister company in Canada have completed their $10 million in facility upgrades. About 80% of that was spent on DPT's operation in San Antonio, where it has a 450,000-square-foot manufacturing plant, as well as a formulation facility.

The company says that work in Texas included significant upgrades to production filling lines, a new compounding suite as well as security improvements to improve GMP compliance and restrict access to the manufacturing floor. The company makes both prescription and over-the-counter products in Texas. The plant there includes a 60,000-square-foot cGMP aerosol manufacturing facility.

The upgrades at Confab, its manufacturing site for complex solid dose, semisolid and liquid products, included work for R&D upgrades, DPT said in a statement.

The CDMO also has manufacturing site in Lakewood, NJ. In 2012, that site received an FDA warning letter for a number problems including release testing failures for an ointment that raised red flags at the FDA. The company responded quickly and received a closeout letter from the regulator 6 months later.

- here's the announcement

Suggested Articles

The FDA has lambasted the Torrent Pharmaceuticals in a warning letter for making OTC meds using water tainted with bacteria.

Eli Lilly is investing $400 million in its Indianapolis site to expand production of insulin and other diabetes meds, and add 100 jobs.

Recipharm has been building its capabilities in sterile injectable and inhalation drugs. Now it is buying a CDMO that manufactures devices for both.